In ob/ob mice, 10 weeks of GAN diet induction showed only a slight degree of fibrosis (Figure S1A and B), on the basis of which semaglutide was able to significantly reduce the level of -SMA expression, while resmetirom showed no significant improvement in fibrosis score and -SMA expression (Figure S1C and D)
A 63-year-old female with allergic and asthmatic symptoms since childhood, fibroids, Hashimotos thyroiditis, experienced diffuse body aches and bone pain, insomnia, brain fog, bloating, food sensitivities, and a need to eat every 23 hours
The serum of 12 healthy individuals with no past COVID-19 experience was used as the control
The dosage can be increased as needed, usually to 5mg, then 7.5 mg, 10 mg, and higher if needed
However, despite the high demand, data shows many patients who begin GLP-1 weight loss treatment do not finish their course of treatment
Many clients start noticing weight loss within the first 46 weeks when used consistently with a healthy diet and lifestyle, though individual results may vary